Annual accounts
Group accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
DUNAD THERAPEUTICS LTD.
Active- 12544797Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- The Officers' Mess, Royston Road, Cambridge CB22 4QH
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Group
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 14/05/2026View PDF (6 pages)
Statement of capital following an allotment of shares on 2026-05-05
- 21/04/2026View PDF (3 pages)
Replacement Filing for the appointment of Mr Michael Bonney as a director
- 16/02/2026View PDF (6 pages)
Statement of capital following an allotment of shares on 2026-02-03
- 09/12/2025View PDF (6 pages)
Statement of capital following an allotment of shares on 2025-12-04
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 01/04/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures DUNAD THERAPEUTICS LTD. filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£-2.25M2025
-125.87%vs 20242024: £8.69M
Total Assets
£530.67K2025
-94.49%vs 20242024: £9.63M
Cash in Bank
£287.46K2025
-96.41%vs 20242024: £8.00M
Total Liabilities
£2.77M2025
206.86%vs 20242024: £903.00K
Employees
72025
-3vs 20242024: 10
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Net assets moved furthest, down 125.87% on 2024. See the full financial analysis for DUNAD THERAPEUTICS LTD..
The full financial record
Four ways through DUNAD THERAPEUTICS LTD.'s filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -84.3% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 7 | -3 |
| 2024 | 10 | +10 |
| 2023 | 0 | -11 |
| 2022 | 11 | +10 |
| 2021 | 1 | – |
Reported employee count increased from 1 in 2021 to 7 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
13Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Secretary | 14/07/2023–Present | 2337 | |
| Director | 20/04/2020–12/10/2022 | 3 | |
| Director | 22/04/2020–Present | 15 | |
| Director | 02/04/2020–20/04/2020 | 1 | |
| Director | 12/10/2022–31/05/2024 | 4 | |
| Director | 21/04/2021–16/07/2022 | 4 | |
| Director | 16/07/2022–14/08/2024 | 0 | |
| Director | 04/05/2022–Present | 0 | |
| Director | 16/07/2022–28/03/2024 | 3 | |
| Director | 21/04/2021–Present | 1 | |
| Director | 14/04/2023–Present | 0 | |
| Director | 14/08/2024–Present | 1 | |
| Director | 28/03/2024–Present | 0 |
Persons with significant control
4Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 22/04/2020–14/08/2024 | 3 | |
| 20/04/2020–14/08/2024 | 3 | |
| 20/04/2020–Present | 3 | |
| 02/04/2020–20/04/2020 | 1 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 61 Since 25/07/2022
- Last 12 months
- 5 -8 vs the year before
- Most recent filing
- 14/05/2026 4 months ago
What changed in the last year
- Share capital (4)Latest 14/05/2026
- Officer changesLatest 21/04/2026
Filing timeline
- 14/05/2026View PDF (6 pages)
Statement of capital following an allotment of shares on 2026-05-05
- 21/04/2026View PDF (3 pages)
Replacement Filing for the appointment of Mr Michael Bonney as a director
- 16/02/2026View PDF (6 pages)
Statement of capital following an allotment of shares on 2026-02-03
- 09/12/2025View PDF (6 pages)
Statement of capital following an allotment of shares on 2025-12-04
- 10/10/2025View PDF (6 pages)
Statement of capital following an allotment of shares on 2025-10-09
- 23/09/2025View PDF (6 pages)
Statement of capital following an allotment of shares on 2025-09-02
- 22/09/2025View PDF (37 pages)
Group of companies' accounts made up to 2024-12-31
- 28/08/2025View PDF (5 pages)
Particulars of variation of rights attached to shares
- 27/08/2025View PDF (6 pages)
Statement of capital following an allotment of shares on 2025-08-20
- 22/08/2025View PDF (2 pages)
Resolutions
- 22/08/2025View PDF (69 pages)
Memorandum and Articles of Association
- 09/05/2025View PDF (5 pages)
Statement of capital following an allotment of shares on 2025-05-07
Showing 12 of 61 filings
See when the next accounts and confirmation statement are due
Similar companies
1 UK company is similar to DUNAD THERAPEUTICS LTD., sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. It is shown below to help you compare competitors and industry peers.
GENEA BIOMEDX UK LIMITED
ActiveOffice 20 Second Floor Innovation House, Ramsgate Road, Sandwich, Kent CT13 9FF
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08314520
- Incorporated
- 30/11/2012
- Employees
- 5
About DUNAD THERAPEUTICS LTD.
A short description of the company, written from its Companies House record.
DUNAD THERAPEUTICS LTD. is a private limited company registered in the United Kingdom, based in The Officers' Mess, Royston Road, Cambridge CB22 4QH. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 6 years 5 months.
The register currently records it as active. Its 2025 accounts report net assets of £-2.25M and 7 employees.
DUNAD THERAPEUTICS LTD.: frequently asked questions
Answered from this company's own registry record and filed figures.
What does DUNAD THERAPEUTICS LTD. do?
Companies House records DUNAD THERAPEUTICS LTD. under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is DUNAD THERAPEUTICS LTD. still active?
DUNAD THERAPEUTICS LTD. is recorded as active on the Companies House register, and has been on it since 02/04/2020.
What are DUNAD THERAPEUTICS LTD.'s latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £-2.25M, total assets of £530.67K, cash in bank of £287.46K and total liabilities of £2.77M.
When did DUNAD THERAPEUTICS LTD. last file with Companies House?
The most recent document on the record is dated 14/05/2026: Statement of capital following an allotment of shares on 2026-05-05, 4 months ago.
When are DUNAD THERAPEUTICS LTD.'s next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs DUNAD THERAPEUTICS LTD.?
Companies House lists 13 officers (7 currently in post) and 4 people with significant control (1 current).